HidekiGarrenMD

Physician

Dr. Garren is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 1994 - 1997
UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1993 - 1994
David Geffen School of Medicine at UCLAClass of 1993

PubMed

1313 citations
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
Christopher Lock, Guy Hermans, Rosetta Pedotti, Andrea Brendolan, Eric E. Schadt
Nature Medicine. 2002-05-01
1116 citations
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
Xavier Montalban, Stephen L. Hauser, Ludwig Kappos, Douglas L. Arnold, Amit Bar-Or
The New England Journal of Medicine. 2017-01-19
1128 citations
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Stephen L. Hauser, Amit Bar-Or, Giancarlo Comi, Gavin Giovannoni, Hans Peter Hartung
The New England Journal of Medicine. 2017-01-19

Biotech Company Prothena Taps Walgreens to Recruit Patients for Alzheimer's Drug ResearchApril 13th, 2023
Walgreens and Prothena Partner to Increase Access and Enrollment in Alzheimer’s Disease Clinical TrialApril 13th, 2023
Prothena Corporation Plc (NASDAQ:PRTA) Q4 2022 Earnings Call TranscriptFebruary 28th, 2023
Join now to see all